About the Authors

Lucette A. Cysique

lcysique@unsw.edu.au

Affiliations University of New South Wales, St. Vincent’s Clinical School, Sydney, Australia, Neuroscience Research Australia, Sydney, Australia, St.Vincent’s Hospital, Neurology and Imaging and HIV Departments, Sydney, Australia, St. Vincent’s Hospital Centre for Applied Medical Research, Sydney, Australia

Kirsten Moffat

Affiliation St.Vincent’s Hospital, Neurology and Imaging and HIV Departments, Sydney, Australia

Danielle M. Moore

Affiliations St.Vincent’s Hospital, Neurology and Imaging and HIV Departments, Sydney, Australia, St. Vincent’s Hospital Centre for Applied Medical Research, Sydney, Australia

Tammy A. Lane

Affiliation AIDS Dementia and HIV Psychiatry Service (ADAHPS) Sydney Hospital and Sydney Eye Hospital, Sydney, Australia

Nicholas W. S. Davies

Affiliation Department of Neurology, Chelsea and Westminster Hospital, London, United Kingdom

Andrew Carr

Affiliations St.Vincent’s Hospital, Neurology and Imaging and HIV Departments, Sydney, Australia, St. Vincent’s Hospital Centre for Applied Medical Research, Sydney, Australia

Bruce J. Brew

Affiliations University of New South Wales, St. Vincent’s Clinical School, Sydney, Australia, St.Vincent’s Hospital, Neurology and Imaging and HIV Departments, Sydney, Australia, St. Vincent’s Hospital Centre for Applied Medical Research, Sydney, Australia

Caroline Rae

Affiliations University of New South Wales, St. Vincent’s Clinical School, Sydney, Australia, Neuroscience Research Australia, Sydney, Australia

Competing Interests

This study was supported by the National Health and Medical Research Council (NHMRC) project grant ID568746 (Cysique-CIA) and the post-doctoral Brain Science University of New South Wales (UNSW) fellowship and salary support for the year 2012 by Merck-Sereno. In addition, Dr. Cysique has received honoraria from ViiV Healthcare and Abbott Ltd. Prof. Brew has received honoraria from ViiV Healthcare, speaker, 2005–2009, ViiV Healthcare, 2010, Boehringer Ingelheim, 2005–2010, Abbott, 2009–2010, Biogen Idec 2006, 2008, and has served on a scientific advisory board for ViiV Healthcare, member 2008, BiogenIdec, member 2007, ViiV Healthcare, member 2010, Merck Serono, member 2010. Prof. Carr has received research funding from Baxter, ViiV Healthcare, MSD and Pfizer, consultancy fees from Gilead Sciences, ViiV Healthcare, and MSD, and speaking fees from Abbott, Bristol-Myers Squibb, Gilead Sciences, ViiV Healthcare and MSD, and has participated in advisory boards of Gilead Sciences, ViiV Healthcare. The other authors have no potential competing interests to declare. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: LAC KM NWSD AC BJB CR. Performed the experiments: LAC KM DMM TAL NWSD. Analyzed the data: LAC CR. Contributed reagents/materials/analysis tools: LAC AC BJB. Wrote the paper: LAC KM DMM TAL NWSD AC BJB CR.